ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Elevance Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ELV

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of Elevance Health, Inc. common stock during the specified Class Period, indicating potential legal issues related to misleading statements made by the company regarding Medicaid costs and premium rates [1][5]. Group 1: Class Action Details - The class action is for investors who purchased Elevance common stock between April 18, 2024, and October 16, 2024, and they may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2][3]. - Investors wishing to serve as lead plaintiff must file a motion with the Court by July 11, 2025 [1][3]. Group 2: Allegations Against Elevance Health - The lawsuit claims that Elevance Health made false or misleading statements about their monitoring of cost trends related to the Medicaid redetermination process, which was not accurately reflected in their financial guidance for 2024 [5]. - It is alleged that the company assured investors that rising Medicaid expenses were adequately accounted for, while in reality, the acuity and utilization of Medicaid members were increasing significantly due to the redetermination process [5]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4].